BRUGNOLI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 221
EU - Europa 122
AS - Asia 64
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 414
Nazione #
US - Stati Uniti d'America 216
IT - Italia 39
CN - Cina 33
FR - Francia 27
DE - Germania 13
CH - Svizzera 12
FI - Finlandia 6
JP - Giappone 6
PL - Polonia 6
SE - Svezia 6
VN - Vietnam 6
SG - Singapore 5
AU - Australia 4
IE - Irlanda 4
AE - Emirati Arabi Uniti 3
CA - Canada 3
GB - Regno Unito 3
TH - Thailandia 3
TW - Taiwan 3
GR - Grecia 2
IN - India 2
MX - Messico 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HK - Hong Kong 1
KZ - Kazakistan 1
MY - Malesia 1
ZA - Sudafrica 1
Totale 414
Città #
Santa Cruz 30
Ashburn 24
Ferrara 22
Fairfield 21
Chongqing 8
Des Moines 8
Buffalo 6
Cambridge 6
Dong Ket 6
Shanghai 6
Stockholm 6
Warsaw 6
Chicago 5
Columbus 5
Lausanne 5
Madison 5
New York 5
San Diego 5
Seattle 5
Woodbridge 5
Dublin 4
Helsinki 4
Modena 4
Nanjing 4
Tokyo 4
Wilmington 4
Bangkok 3
Boardman 3
Clearwater 3
Cologne 3
Houston 3
Los Angeles 3
Paris 3
San Jose 3
Toronto 3
Écublens 3
Coimbatore 2
Dallas 2
Elmshorn 2
Frankfurt am Main 2
Guangzhou 2
Hangzhou 2
Henderson 2
Lappeenranta 2
Lexington 2
Menlo Park 2
Neuchatel 2
Oxford 2
San Francisco 2
Taichung 2
Aalst 1
Adelaide 1
Almaty 1
Ann Arbor 1
Atlanta 1
Beijing 1
Brisbane 1
Cairo 1
Carmignano di Brenta 1
Castelcovati 1
Chengdu 1
Council Bluffs 1
Dainohara 1
Ferrara di Monte Baldo 1
Florence 1
Geneva 1
Grenoble 1
Hershey 1
Hong Kong 1
Iseo 1
Iztapalapa 1
Kuala Lumpur 1
Las Vegas 1
London 1
Medford 1
Melbourne 1
Muizenberg 1
Muroran 1
Norwalk 1
Nuremberg 1
Padova 1
Palo Alto 1
Pasadena 1
Pavia 1
Pearland 1
Riva 1
Sacramento 1
Saint Petersburg 1
Scranton 1
St Louis 1
Sydney 1
Tainan City 1
Tlalpan 1
Toledo 1
Vicenza 1
Villaz-Saint-Pierre 1
Totale 317
Nome #
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease, file 097ccc8a-9bab-450f-9e98-c5824f903d52 82
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice, file e309ade1-5825-3969-e053-3a05fe0a2c94 72
Role of LRRK2 in the regulation of dopamine receptor trafficking, file e309ade1-a6c4-3969-e053-3a05fe0a2c94 60
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia, file e309ade1-acb4-3969-e053-3a05fe0a2c94 59
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models, file e309ade2-a3ae-3969-e053-3a05fe0a2c94 51
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia, file e309ade5-0042-3969-e053-3a05fe0a2c94 34
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia, file ed9f748f-2295-43dd-958c-1fca8b754276 11
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats, file e309ade3-287f-3969-e053-3a05fe0a2c94 10
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity, file e309ade5-310c-3969-e053-3a05fe0a2c94 8
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives, file e309ade2-5f84-3969-e053-3a05fe0a2c94 7
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia, file e309ade5-0987-3969-e053-3a05fe0a2c94 7
Novel therapeutic targets in levodopa-induced dyskinesia: in vivo studies in rodent models of Parkinson’s disease, file e309ade5-9608-3969-e053-3a05fe0a2c94 5
Novel therapeutic targets in levodopa-induced dyskinesia: in vivo studies in rodent models of Parkinson’s disease, file e309ade5-960a-3969-e053-3a05fe0a2c94 4
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity, file e309ade0-a262-3969-e053-3a05fe0a2c94 3
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity, file e309ade2-7421-3969-e053-3a05fe0a2c94 2
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease, file e309ade2-a773-3969-e053-3a05fe0a2c94 2
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia, file e309ade1-07cf-3969-e053-3a05fe0a2c94 1
Totale 418
Categoria #
all - tutte 1.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 1 2 0 0 0 0 0
2020/202154 0 0 0 0 0 0 0 0 10 19 18 7
2021/202284 1 5 10 0 5 1 7 7 4 3 30 11
2022/2023134 1 7 27 19 6 18 9 7 16 5 16 3
2023/2024140 14 10 13 14 16 13 5 17 13 17 8 0
Totale 418